Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Burrill & Company Venture Team among the “Top 100 People in Bioenergy”October 13, 2010
SAN FRANCISCO – October 13, 2010 – Burrill & Company is pleased to announce that its Venture Capital team focused on bioenergy investing has been named among the “Top 100 People in Bioenergy” by the publication Biofuels Digest. G.Steven Burrill, CEO, Roger E. Wyse, Managing Director, Dr. John Hamer, Managing Director, and Greg B. Young, Director join government, company, investment and association leaders involved in the research, development and commercialization of bioenergy that made the list.
In recognizing the Burrill team the publication writes…“we’ve paired a quartet of partners and investors at Burrill & Company, who expanded out of a key position in life sciences and into biofuels, and have been notable in the development of Gevo, Cobalt Technologies, Chromatin and other key players. They are also noted for key roles played in industry associations like BIO, and at industry events such as the Advanced Biofuels Leadership Conference, as well as conducting a series of their own industry events and publishing a lot of research on industry trends.”
The Top 100 list was compiled from suggestions and subsequent voting by readers of the publication. “I am delighted that we have been recognized by Biofuels Digest,” said G. Steven Burrill, CEO, Burrill & Company. “Our very experienced Venture Capital team has made significant investments in the bioenergy sector for over a decade now and we rank among the investment leaders in this world critical industry. We are continuing to build upon our expertise in this area as we see tremendous ongoing investment opportunities.”